Trinity Capital Inc. Exits Its Equity Position in Core Scientific
Rhea-AI Summary
Trinity Capital (Nasdaq: TRIN) announced the completion of its liquidation of Core Scientific (CORZ) shares. These shares were received to satisfy a $28.3 million claim from Core's Chapter 11 bankruptcy, following a $30 million equipment financing provided in 2021. The liquidation of 5,640,373 shares at an average price of $5.13 per share generated $29 million in total proceeds. Including loan interest payments, Trinity achieved an internal rate of return of 17.7% on its initial investment.
Positive
- Liquidation of Core Scientific shares resulted in $29 million in proceeds.
- Internal rate of return on the initial investment was 17.7%.
- Successful exit strategy following Core Scientific's Chapter 11 bankruptcy.
- Achieved financial return despite Core's bankruptcy situation.
Negative
- The $30 million equipment financing to Core resulted in a $28.3 million bankruptcy claim, indicating a partial loss.
- The average share price of $5.13 may suggest lower-than-expected market valuation.
News Market Reaction – TRIN
On the day this news was published, TRIN declined 0.60%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Liquidation of shares results in a return of
Trinity provided
About Trinity Capital Inc.
Trinity (Nasdaq: TRIN), an internally managed business development company, is a leading provider of diversified financial solutions to growth-stage companies with institutional equity investors. Trinity's investment objective is to generate current income and, to a lesser extent, capital appreciation through investments, including term loans, equipment financings and equity-related investments. Trinity believes it is one of only a select group of specialty lenders that has the depth of knowledge, experience, and track record in lending to growth-stage companies. For more information, please visit the Company's website at www.trinitycap.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/trinity-capital-inc-exits-its-equity-position-in-core-scientific-302165275.html
SOURCE Trinity Capital Inc.
FAQ
What is the outcome of Trinity Capital's liquidation of Core Scientific shares?
When did Trinity Capital complete the liquidation of Core Scientific shares?
What was the initial investment provided by Trinity Capital to Core Scientific?
How many Core Scientific shares did Trinity Capital sell?
What was the weighted average price per share for the Core Scientific shares sold by Trinity Capital?
What internal rate of return did Trinity Capital achieve from the liquidation?